NIH awards Indiana researcher $44.7M for early onset Alzheimer’s study using imaging

Melissa Rohman | | Health Imaging | Diagnostic Imaging
6815.x42491.jpg

Liana Apostolova, MD, a researcher at the Indiana University School of Medicine, has won a five-year $44.7 million research grant from the National Institutes of Health (NIH) to study early-onset Alzheimer's disease with MRI and PET imaging, according to an Oct. 4 report by the Indianapolis Business Journal.  

“It’s frustrating to us as researchers because we still don’t understand all the mechanisms of Alzheimer’s disease and our treatments that have tried and failed,” Apostolova told IBJ.  

The multi-institutional study will involve 400 early-onset Alzheimer's patients who have mild cognitive impairment or mild Alzheimer’s disease with PET scans that showed buildup of beta amyloid protein in the brain.  

Along with 100 healthy control participants, these patients will also undergo cognitive testing, MRI and PET scans, the collection of spinal fluid and DNA testing at yearly intervals for the next three years.  

See the entire article below. 

IU researcher wins $44.7M to study rare form of Alzheimer's disease

""
Melissa Rohman

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.